The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
Open accessAbstract
Anemia is a common complication in chronic kidney disease (CKD), and is associated with a reduced quality of life, and an increased morbidity and mortality. The mechanisms involved in anemia associated to CKD are diverse and complex. They include a decrease in endogenous erythropoietin (EPO) production, absolute and/or functional iron deficiency, and inflammation with increased hepcidin levels, among others. Patients are most commonly managed with oral or intravenous iron supplements and with erythropoiesis stimulating agents (ESA). However, these treatments have associated risks, and sometimes are insufficiently effective. Nonetheless, in the last years, there have been some remarkable advances in the treatment of CKD-related anemia, which have raised great expectations. On the one hand, a novel family of drugs has been developed: the hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs). These agents induce, among other effects, an increase in the production of endogenous EPO, improve iron availability and reduce hepcidin levels. Some of them have already received marketing authorization. On the other hand, recent clinical trials have elucidated important aspects of iron supplementation, which may change the treatment targets in the future. This article reviews the current knowledge of the pathophysiology CKD-related anemia, current and future therapies, the trends in patient management and the unmet goals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K.-U., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,104
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Ponikowski, P., van Veldhuisen, D. J., Comin-Colet, J., Ertl, G., Komajda, M., Mareev, V., McDonagh, T., Parkhomenko, A., Tavazzi, L., Levesque, V., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu385 · Cited by 1,242
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
HIF transcription factors, inflammation, and immunity
Palazon, A., Goldrath, A. W., Nizet, V., & Johnson, R. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.008 · Cited by 1,195
Kalantar-Zadeh, K. (2017) · American Journal of Nephrology · doi:10.1159/000455387 · Cited by 1,148
Identification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127 · cited 1×
“ERFE is a hormone produced by erythroblasts in response to EPO (57).”
BackgroundPonikowski, P., Kirwan, B.-A., Anker, S. D., McDonagh, T., Dorobantu, M., Drozdz, J., Fabien, V., Filippatos, G., Göhring, U. M., Keren, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32339-4 · Cited by 795
Prevalence of Anemia in Chronic Kidney Disease in the United States
Stauffer, M. E., & Fan, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084943 · Cited by 666
Jones, M., Ibels, L., Schenkel, B., & Zagari, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 665
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
Chen, N., Hao, C., Liu, B.-C., Lin, H., Wang, C., Xing, C., Liang, X., Jiang, G., Liu, Z., Li, X., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901713 · Cited by 621
Ganz, T. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1804281 · Cited by 589
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
Chen, N., Hao, C., Peng, X., Lin, H., Yin, A., Hao, L., Tao, Y., Liang, X., Liu, Z., Xing, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813599 · Cited by 582
Effect of inflammatory cytokines on hypoxia-induced erythropoietin production
Faquin, W., Schneider, T., & Goldberg, M. (1992) · Blood · doi:10.1182/blood.v79.8.1987.1987 · Cited by 532
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
Macdougall, I. C., White, C., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., McMurray, J. J. V., Murray, H., Tomson, C. R. V., Wheeler, D. C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1810742 · Cited by 502
Lewis, G. D., Malhotra, R., Hernandez, A. F., McNulty, S. E., Smith, A., Felker, G. M., Tang, W. H. W., LaRue, S. J., Redfield, M. M., Semigran, M. J., et al. (2017) · JAMA · doi:10.1001/jama.2017.5427 · Cited by 480
Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α
Freedman, S. J., Sun, Z.-Y. J., Poy, F., Kung, A. L., Livingston, D. M., Wagner, G., & Eck, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082117899 · Cited by 455
Inflammation and Progression of CKD: The CRIC Study
Amdur, R. L., Feldman, H. I., Gupta, J., Yang, W., Kanetsky, P., Shlipak, M., Rahman, M., Lash, J. P., Townsend, R. R., Ojo, A., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13121215 · Cited by 452
van Veldhuisen, D. J., Ponikowski, P., van der Meer, P., Metra, M., Böhm, M., Doletsky, A., Voors, A. A., Macdougall, I. C., Anker, S. D., Roubert, B., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027497 · Cited by 423
How the Target Hemoglobin of Renal Anemia Should Be?
Mimura, I., Tanaka, T., & Nangaku, M. (2015) · Nephron · doi:10.1159/000440849 · Cited by 416
Renal handling of calcium and phosphate during mineralocorticoid “escape” in man
Rastegar, A., Agus, Z., Connor, T. B., & Goldberg, M. (1972) · Kidney International · doi:10.1038/ki.1972.107 · Cited by 397
Parfrey, P. S., Foley, R. N., Wittreich, B. H., Sullivan, D. J., Zagari, M. J., & Frei, D. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121039 · Cited by 373
Jankowska, E. A., Tkaczyszyn, M., Suchocki, T., Drozd, M., von Haehling, S., Doehner, W., Banasiak, W., Filippatos, G., Anker, S. D., & Ponikowski, P. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.473 · Cited by 346
CIS3/SOCS-3 Suppresses Erythropoietin (EPO) Signaling by Binding the EPO Receptor and JAK2
Sasaki, A., Yasukawa, H., Shouda, T., Kitamura, T., Dikic, I., & Yoshimura, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003456200 · Cited by 342
Hypoxia-inducible factor 2 regulates hepatic lipid metabolism
Rankin, E. B., Rha, J., Selak, M. A., Unger, T. L., Keith, B., Liu, Q., & Haase, V. H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00200-09 · Cited by 338
Erythropoietin resistance: the role of inflammation and pro‐inflammatory cytokines
Macdougall, I. C., & Cooper, A. C. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_11.39 · Cited by 336
Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
Batchelor, E. K., Kapitsinou, P., Pergola, P. E., Kovesdy, C. P., & Jalal, D. I. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020213 · Cited by 334
Provenzano, R., Besarab, A., Sun, C. H., Diamond, S. A., Durham, J. H., Cangiano, J. L., Aiello, J. R., Novak, J. E., Lee, T., Leong, R., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06890615 · Cited by 290
The multifaceted role of iron in renal health and disease
van Swelm, R. P. L., Wetzels, J. F. M., & Swinkels, D. W. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0197-5 · Cited by 275
Provenzano, R., Besarab, A., Wright, S., Dua, S., Zeig, S., Nguyen, P., Poole, L., Saikali, K. G., Saha, G., Hemmerich, S., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.12.020 · Cited by 263
Jahn, M. R., Andreasen, H. B., Fütterer, S., Nawroth, T., Schünemann, V., Kolb, U., Hofmeister, W., Muñoz, M., Bock, K., Meldal, M., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.03.016 · Cited by 256
Inflammation and Hypoxia: HIF and PHD Isoform Selectivity
Watts, E. R., & Walmsley, S. R. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.10.006 · Cited by 237
Locatelli, F., Covic, A., Eckardt, K.-U., Wiecek, A., Vanholder, R., & on behalf of the ERA-EDTA ERBP Advisory Board (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn653 · Cited by 218
Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets
Serebrovska, Z. O., Chong, E. Y., Serebrovska, T. V., Tumanovska, L. V., & Xi, L. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00554-8 · Cited by 218
The regulation of iron transport
Frazer, D. M., & Anderson, G. J. (2014) · BioFactors · doi:10.1002/biof.1148 · Cited by 216
Astor, B. C., Coresh, J., Heiss, G., Pettitt, D., & Sarnak, M. J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.055 · Cited by 214
Association of anemia with outcomes in men with moderate and severe chronic kidney disease
Kovesdy, C. P., Trivedi, B. K., Kalantar-Zadeh, K., & Anderson, J. E. (2006) · Kidney International · doi:10.1038/sj.ki.5000105 · Cited by 208
Libregts, S. F., Gutiérrez, L., de Bruin, A. M., Wensveen, F. M., Papadopoulos, P., van Ijcken, W., Özgür, Z., Philipsen, S., & Nolte, M. A. (2011) · Blood · doi:10.1182/blood-2010-10-315218 · Cited by 204
Akizawa, T., Iwasaki, M., Yamaguchi, Y., Majikawa, Y., & Reusch, M. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019060623 · Cited by 202
A Well-Resolved Phylogeny of the Trees of Puerto Rico Based on DNA Barcode Sequence Data
Muscarella, R., Uriarte, M., Erickson, D. L., Swenson, N. G., Zimmerman, J. K., & Kress, W. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112843 · Cited by 190
Pagé, E. L., Chan, D. A., Giaccia, A. J., Levine, M., & Richard, D. E. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0612 · Cited by 181
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
van der Putten, K., Braam, B., Jie, K. E., & Gaillard, C. A. (2008) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0655 · Cited by 180
Physiological Effects of Chronic Hypoxia
West, J. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1612008 · Cited by 172
Filippatos, G. S., Farmakis, D. T., Colet, J. C., Dickstein, K., Lüscher, T. F., Willenheimer, R. B., Parissis, J., Gaudesius, G., Mori, C., Rothe, B. V. E., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft099 · Cited by 171
Microbiota intestinal en la enfermedad renal crónica
Cigarrán, S., Parra, E. G., & Cases, A. (2016) · Nefrología · doi:10.1016/j.nefro.2016.05.008 · Cited by 164
Self-citationHemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study
Rostoker, G., Griuncelli, M., Loridon, C., Couprie, R., Benmaadi, A., Bounhiol, C., Roy, M., Machado, G., Janklewicz, P., Drahi, G., et al. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.01.015 · Cited by 161
Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling
Souma, T., Nezu, M., Nakano, D., Yamazaki, S., Hirano, I., Sekine, H., Dan, T., Takeda, K., Fong, G.-H., Nishiyama, A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121184 · Cited by 160
Liu, W., Zhang, S., Nekhai, S. A., & Liu, S. (2020) · Current Clinical Microbiology Reports · doi:10.1007/s40588-020-00140-w · Cited by 157
Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations
Dallalio, G. A., Law, E., & Means, R. T. (2005) · Blood · doi:10.1182/blood-2005-07-2854 · Cited by 150
Palmer, S. C., Saglimbene, V. M., Mavridis, D., Salanti, G., Craig, J. C., Tonelli, M. A., Wiebe, N., & Strippoli, G. F. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010590.pub2 · Cited by 145
Nguyen, A. D., McDonald, J. G., Bruick, R. K., & DeBose‐Boyd, R. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704976200 · Cited by 142
Wong, M. M. Y., Tu, C., Li, Y., Perlman, R. L., Pecoits-Filho, R., Lopes, A. A., Narita, I., Reichel, H., Port, F. K., Sukul, N., et al. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfz091 · Cited by 140
Economic Burden of Anemia in an Insured Population
Nissenson, A. R., Wade, S. W., Goodnough, L. T., Knight, K. K., & Dubois, R. W. (2005) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2005.11.7.565 · Cited by 132
Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells
Wenger, R. H., & Hoogewijs, D. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00736.2009 · Cited by 129
Pan, X., Suzuki, N., Hirano, I., Yamazaki, S., Minegishi, N., & Yamamoto, M. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025839 · Cited by 123
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD
Umanath, K., Jalal, D. I., Greco, B., Umeukeje, E. M., Reisin, E., Manley, J., Zeig, S., Negoi, D., Hiremath, A. N., Blumenthal, S. S., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014080842 · Cited by 121
Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
Fishbane, S. N., Block, G. A., Loram, L. C., Neylan, J. F., Pérgola, P. E., Uhlig, K., & Chertow, G. M. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016101053 · Cited by 120
Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
Kaplan, J., Sharma, N., & Dikdan, S. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020389 · Cited by 120
Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis
Sakaguchi, Y., Hamano, T., Wada, A., & Masakane, I. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018101007 · Cited by 118
Epidemiology of Chronic Kidney Disease in Heart Failure
Ahmed, A., & Campbell, R. C. (2008) · Heart Failure Clinics · doi:10.1016/j.hfc.2008.03.008 · Cited by 117
Pratt, M. C., Lewis‐Barned, N., Walker, R., Bailey, R., Shand, B., & Livesey, J. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb05644.x · Cited by 115
Chan, M. C., Ilott, N. E., Schödel, J., Sims, D., Tumber, A., Lippl, K., Mole, D. R., Pugh, C. W., Ratcliffe, P. J., Ponting, C. P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749291 · Cited by 113
Akizawa, T., Otsuka, T., Reusch, M., & Ueno, M. (2019) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12888 · Cited by 108
Fehr, T. H., Ammann, P., Garzoni, D., Korte, W. C., Fierz, W., Rickli, H., & Wuthrich, R. P. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00880.x · Cited by 107
Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients
Johansen, K. L., Finkelstein, F. O., Revicki, D. A., Evans, C., Wan, S., Gitlin, M. D., & Agodoa, I. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr697 · Cited by 101
Inker, L. A., Grams, M. E., Levey, A. S., Coresh, J., Círillo, M., Collins, J. F., Gansevoort, R. T., Gutiérrez, O. M., Hamano, T., Heine, G. H., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.08.013 · Cited by 98
Cytokine gene polymorphism and progression of renal and cardiovascular diseases
Rao, M., Wong, C. S., Kanetsky, P. A., Girndt, M., Stenvinkel, P., Reilly, M. P., & Raj, D. S. (2007) · Kidney International · doi:10.1038/sj.ki.5002391 · Cited by 97
Do two intravenous iron sucrose preparations have the same efficacy?
Rottembourg, J. B., Kadri, A., Leonard, E., Dansaert, A., & Lafuma, A. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr024 · Cited by 95
Portolés, J. M., Górriz, J. L., Rubio, E., de Álvaro, F., García, F., Alvarez-Chivas, V., Aranda, P., Martínez‐Castelao, A., & NADIR-3 Study Group (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-2 · Cited by 95
Self-citationNeiser, S., Rentsch, D., Dippon, U., Kappler, A. A., Weidler, P. G., Göttlicher, J., Steininger, R., Wilhelm, M., Braitsch, M., Funk, F., et al. (2015) · BioMetals · doi:10.1007/s10534-015-9845-9 · Cited by 93
Awan, A. A., Walther, C. P., Richardson, P., Shah, M., Winkelmayer, W. C., & Navaneethan, S. D. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz192 · Cited by 93
Macdougall, I. C., Bhandari, S., White, C., Anker, S. D., Farrington, K., Kalra, P. A., Mark, P. B., McMurray, J. J. V., Reid, C., Robertson, M., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019090972 · Cited by 91
Minutolo, R., Locatelli, F., Gallieni, M. A., Bonofiglio, R., Fuíano, G., Oldrizzi, L., Conte, G., Nicola, L. D., Mangione, F., Esposito, P. B., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft338 · Cited by 90
Toblli, J. E., Gennaro, F. D., & Rivas, C. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2014.12.161 · Cited by 89
Taniguchi, S., Dai, C.-H., Price, J. O., & Krantz, S. B. (1997) · Blood · doi:10.1182/blood.v90.6.2244 · Cited by 87
Evans, M., Bower, H., Cockburn, E., Jacobson, S. H., Barany, P. F., & Carrero, J. J. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa054 · Cited by 86
Vaziri, N. D., & Zhou, X. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn601 · Cited by 85
Lefèbvre, P., Vekeman, F., Sarokhan, B. J., Enny, C., Provenzano, R., & Crémieux, P. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x132541 · Cited by 83
Safety of Intravenous Iron in Dialysis
Hougen, I., Collister, D., Bourrier, M., Ferguson, T. W., Hochheim, L., Komenda, P. V. J., Rigatto, C., & Tangri, N. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05390517 · Cited by 76
The Effect of Altitude on Dosing and Response to Erythropoietin in ESRD
Brookhart, M. A., Schneeweiß, S., Avorn, J., Bradbury, B. D., Rothman, K. J., Fischer, M. A., Mehta, J., & Winkelmayer, W. C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111181 · Cited by 75
Klip, I. T., Jankowska, E. A., Enjuanes, C., Voors, A. A., Banasiak, W., Bruguera, J., Rozentryt, P., Poloński, L., van Veldhuisen, D. J., Ponikowski, P. P., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.84 · Cited by 74
Minutolo, R., Conte, G., Cianciaruso, B., Bellizzi, V., Camocardi, A., Paola, L. D., & Nicola, L. D. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs007 · Cited by 69
Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease
Natale, P., Palmer, S. C., Jauré, A., Hodson, E. M., Ruospo, M., Cooper, T. E., Hahn, D., Saglimbene, V. M., Craig, J. C., & Strippoli, G. F. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013751.pub2 · Cited by 69
Gandra, S. R., Finkelstein, F. O., Bennett, A. V., Lewis, E. F., Brazg, T., & Martin, M. L. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.09.019 · Cited by 67
Kortman, G. A. M., Reijnders, D., & Swinkels, D. W. (2017) · Hemodialysis International · doi:10.1111/hdi.12553 · Cited by 67
Cho, M. E., Hansen, J. L., Peters, C. B., Cheung, A. K., Greene, T., & Sauer, B. C. (2019) · Kidney International · doi:10.1016/j.kint.2019.04.029 · Cited by 66
Wagner, M., Alam, A., Zimmermann, J., Rauh, K., Batzner, A., Raff, U., Wanner, C., & Schramm, L. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00380111 · Cited by 65
Nonhematological Benefits of Iron
Agarwal, R. (2007) · American Journal of Nephrology · doi:10.1159/000107927 · Cited by 64
Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease
Eisenga, M. F., Nolte, I. M., van der Meer, P., Bakker, S. J. L., & Gaillard, S. (2018) · BMC Nephrology · doi:10.1186/s12882-018-1021-3 · Cited by 61
Akizawa, T., Macdougall, I. C., Berns, J. S., Bernhardt, T., Staedtler, G., Taguchi, M., Iekushi, K., & Krueger, T. (2019) · American Journal of Nephrology · doi:10.1159/000499111 · Cited by 58
Marsch, E., Demandt, J. A. F., Theelen, T. L., Tullemans, B. M. E., Wouters, K., Boon, M. R., van Dijk, T. H., Gijbels, M. J., Dubois, L. J., Meex, S. J. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw156 · Cited by 53
Vogel, S., Wottawa, M., Farhat, K., Zieseniß, A., Schnelle, M., Le-Huu, S. K.-A., von Ahlen, M., Malz, C. R., Camenisch, G., & Katschinski, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.132985 · Cited by 48
Núñez, J. E., Monmeneu, J. V., Mollar, A., Núñez, E., Bodı́, V., Miñana, G., García‐Blas, S., Santas, E., Agüero, J., Chorro, F. J., et al. (2016) · ESC Heart Failure · doi:10.1002/ehf2.12101 · Cited by 46
Lopes, M. B., Tu, C., Zee, J., Guedes, M. H., Pisoni, R. L., Robinson, B. M., Foote, B. S., Hedman, K., James, G., Lopes, A. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79254-6 · Cited by 46
Interleukin‐1 and Tumor Necrosis Factor‐α Inhibit Erythropoietin Production in Vitroa
Fandrey, J., & JELKMANN, W. E. B. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb17252.x · Cited by 45
Dose-dependent effect of angiotensin II on human erythropoietin production
Freudenthaler, S. M., Lucht, I., Schenk, T., et al. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004249900238 · Cited by 44
Macdougall, I. C., Bock, A. H., Carrera, F., Eckardt, K., Gaillard, S., Wyck, D. V., Roubert, B., Cushway, T., Roger, S. D., & on Behalf of the FIND-CKD Study Investigators (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft424 · Cited by 41
Rostoker, G., Loridon, C., Griuncelli, M., Rabaté, C., Lepeytre, F., Ureña, P., Issad, B., Ghali, N., & Cohen, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.020 · Cited by 41
Iron–sulfur clusters in nucleic acid metabolism: Varying roles of ancient cofactors
Khodour, Y., Kaguni, L. S., & Stiban, J. (2019) · The Enzymes · doi:10.1016/bs.enz.2019.08.003 · Cited by 40
Palmer, S. C., Salanti, G., Craig, J. C., Mavridis, D., & Strippoli, G. F. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010590 · Cited by 35
Holman, R. E., Olynyk, J. K., Kulkarni, H., & Ferrari, P. (2016) · Nephrology · doi:10.1111/nep.12735 · Cited by 29
Stack, A. G., Alghali, A., Li, X., Ferguson, J. P., Casserly, L. F., Cronin, C. J., Reddan, D. N., Hussein, W. F., & Elsayed, M. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx060 · Cited by 29
Locatelli, F., Hannedouche, T. P., Fishbane, S. N., Morgan, Z., Oguey, D., & White, W. B. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01380219 · Cited by 28
Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19
Fishbane, S. N., & Hirsch, J. S. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.002 · Cited by 27
Cases, A., Puchades, M. J., de Sequera, P., Quiroga, B., Martín-Rodriguez, L., Górriz, J. L., & Portolés, J. M. (2021) · Nefrología · doi:10.1016/j.nefro.2020.11.003 · Cited by 24
Self-citationMinutolo, R., Garofalo, C., Chiodini, P., Aucella, F., Vecchio, L. D., Locatelli, F., Scaglione, F., & Nicola, L. D. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa088 · Cited by 23
Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients
Hahn, D., Esezobor, C. I., Elserafy, N. A., Webster, A. C., & Hodson, E. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011690.pub2 · Cited by 16
The noblesse of kidney physiology
Eckardt, K. (2019) · Kidney International · doi:10.1016/j.kint.2019.10.007 · Cited by 12
Cases, A., Puchades, M. J., de Sequera, P., Quiroga, B., Martín-Rodriguez, L., Górriz, J. L., & Portolés, J. M. (2021) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2020.11.011 · Cited by 10
Self-citationInsuficiencia cardíaca en la enfermedad renal y déficit de hierro: importancia de la ferroterapia
Cases, A., López, R. O., & Portolés, J. M. (2017) · Nefrología · doi:10.1016/j.nefro.2017.03.027 · Cited by 8
Self-citationHypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease
Natale, P., Palmer, S. C., Tong, A., Ruospo, M., Hodson, E. M., Cooper, T. E., Hahn, D., & Strippoli, G. F. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013751 · Cited by 5
Heart failure in patients with kidney disease and iron deficiency: The role of iron therapy
Cases, A., López, R. O., & Portolés, J. M. (2017) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2017.11.009 · Cited by 1
Self-citation
Cited by
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease
Matsushita, K., Ballew, S. H., Wang, A. Y.-M., Kalyesubula, R., Schaeffner, E., & Agarwal, R. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00616-6 · Cited by 670
Bayır, H., Dixon, S. J., Tyurina, Y. Y., Kellum, J. A., & Kagan, V. E. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00689-x · Cited by 331
Metadata
- Authors
- Portolés, J., Martín, L., Broseta, J. J., & Cases, A.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2021-03-26
- Volume
- 8
- Pages
- 642296-642296
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W3147940220
- Cited by
- 369
- References
- 120
- FWCI
- 28.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.